Tagged with Biotech

Taiwan HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then goes on to discuss the company’s innovative pipeline of stem cell therapies.   Overall, our offering will be a great…

Taiwan Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the island’s life sciences sector forward.   Johnsee Lee – Chairman, Taiwan Bio Industry Organization Dr Johnsee Lee holds a number…

Germany Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to bolster its development pipeline and create transformative biotechnological solutions.   German pharmaceutical company Bayer AG is setting its sights on…

China Zheru Zhang and Jielun Zhu of I-Mab Biopharma, shares their vision for the ambitious biotech company looking to develop their dual-pronged strategy of in-licensing ‘fast-to-market’ assets for their China portfolio while accelerating proof-of-concept of their internally developed candidates; what it means to operate at ‘I-Mab speed’, not just ‘China Speed’;…

Sweden BioArctic is a Swedish biopharma company with the vision to become a world-leader in the research and development of disease-modifying treatments for patients with neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, and pioneering treatment methods for complete spinal cord injuries. Gunilla Osswald, CEO, explains how BioArctic is uniquely…

Taiwan Albert Lu (founder) and Helen Chiu (co-founder) of Tripod Nano Technology (TPNT), introduce the concept of the original innovative manufacturer (OIM) of metal nanoparticle colloidal solutions and highlight the company’s unique technology as the first eco-efficiency production platform. Lu goes on to comment on the application of nanotech in the…

China Junshi Biosciences is an innovation-driven biopharmaceutical company with a focus on discovery and innovative drugs. Dr Li Ning, CEO, discusses being the first Chinese company to successfully launch a domestically-developed PD-1 cancer drug (toripalimab) in China, their commercialization and pricing strategies and the exciting new products and milestones that we…

Taiwan Lily Wu, CEO of PapiVax, discusses the biotechs initiative pipeline for the treatment of HPV related diseases and cancers and goes on to elaborate the company’s development and future partnership strategies. Wu also discusses the unique structure of PapiVax as a lean, R&D and research-driven biotech which is powered by…

China Transcenta’s Xueming Qian outlines the new company’s origins, the space it seeks to fill within the highly competitive Chinese oncology market, and where Chinese biotech stands globally in 2019.   I did not want to work on an antibody similar to the dozens already in clinical trials, I wanted to…

Sweden Mathias Uhlén is a world-renowned microbiology researcher at the KTH Royal Institute of Technology. Since 2003, he has led the Human Protein Atlas (HPA) project, an international effort to systematically map the human proteome and transcriptome. Among his many other achievements, he was also the founding director of the Science…

Biotech Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd., shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in 2010. Dr. Tsao goes on to explain the company’s unique multiplexing technology based on the πCode™ MicroDisc (‘pi-Code MicroDiscs’), and…

Bayer Tomer Feffer, Country Division Head Scandinavia & MD Bayer Sweden, shares his enthusiasm for Sweden’s innovative spirit and how Bayer is leveraging it through partnerships with medical technology and digital health startups. He also talks about the strategic importance of Sweden for Bayer as an early adopter of new technologies,…